PT  - JOURNAL ARTICLE
AU  - Lassau, Nathalie
AU  - Ammari, Samy
AU  - Chouzenoux, Emilie
AU  - Gortais, Hugo
AU  - Herent, Paul
AU  - Devilder, Matthieu
AU  - Soliman, Samer
AU  - Meyrignac, Olivier
AU  - Talabard, Marie-Pauline
AU  - Lamarque, Jean-Philippe
AU  - Dubois, Remy
AU  - Loiseau, Nicolas
AU  - Trichelair, Paul
AU  - Bendjebbar, Etienne
AU  - Garcia, Gabriel
AU  - Balleyguier, Corinne
AU  - Merad, Mansouria
AU  - Stoclin, Annabelle
AU  - Jegou, Simon
AU  - Griscelli, Franck
AU  - Tetelboum, Nicolas
AU  - Li, Yingping
AU  - Verma, Sagar
AU  - Terris, Matthieu
AU  - Dardouri, Tasnim
AU  - Gupta, Kavya
AU  - Neacsu, Ana
AU  - Chemouni, Frank
AU  - Sefta, Meriem
AU  - Jehanno, Paul
AU  - Bousaid, Imad
AU  - Boursin, Yannick
AU  - Planchet, Emmanuel
AU  - Azoulay, Mikael
AU  - Dachary, Jocelyn
AU  - Brulport, Fabien
AU  - Gonzalez, Adrian
AU  - Dehaene, Olivier
AU  - Schiratti, Jean-Baptiste
AU  - Schutte, Kathryn
AU  - Pesquet, Jean-Christophe
AU  - Talbot, Hugues
AU  - Pronier, Elodie
AU  - Wainrib, Gilles
AU  - Clozel, Thomas
AU  - Barlesi, Fabrice
AU  - Bellin, Marie-France
AU  - Blum, Michael G. B.
TI  - Integration of clinical characteristics, lab tests and a deep learning CT scan analysis to predict severity of hospitalized COVID-19 patients
AID  - 10.1101/2020.05.14.20101972
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.14.20101972
4099  - http://medrxiv.org/content/early/2020/10/06/2020.05.14.20101972.short
4100  - http://medrxiv.org/content/early/2020/10/06/2020.05.14.20101972.full
AB  - The SARS-COV-2 pandemic has put pressure on Intensive Care Units, so that identifying predictors of disease severity is a priority. We collected 58 clinical and biological variables, chest CT scan data (506,341 images), and radiology reports from 1,003 coronavirus-infected patients from two French hospitals. We trained a deep learning model based on CT scans to predict severity; this model was more discriminative than a radiologist quantification of disease extent. We showed that neural network analysis of CT-scan brings unique prognosis information, although it is correlated with other markers of severity (oxygenation, LDH, and CRP). To provide a multimodal severity score, we developed AI-severity that includes 5 clinical and biological variables (age, sex, oxygenation, urea, platelet) as well as the CT deep learning model. When comparing AI-severity with 11 existing scores for severity, we find significantly improved prognosis performance; AI-severity can therefore rapidly become a reference scoring approach.Competing Interest StatementThe authors declare the following competing interests: Employment: Michael Blum, Paul Herent, Rémy Dubois, Nicolas Loiseau, Paul Trichelair, Etienne Bendjebbar, Simon Jégou, Meriem Sefta, Paul Jehanno, Fabien Brulport, Olivier Dehaene, Jean-Baptiste Schiratti, Kathryn Schutte, Elodie Pronier, Jocelyn Dachary, Adrian Gonzalez, employed by Owkin Co-founders of Owkin Inc : Thomas Clozel, Gilles Wainrib. Funding StatementOwkin employees are paid by Owkin, Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has received approval of ethic committees from the two hospitals and authors submitted a declaration to the National Commission of Data Processing and Liberties (Number INDS MR5413020420, CNIL) in order to get registered in the medical studies database and respect the General Regulation on Data Protection (RGPD) requirements.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset of patients hospitalized at Kremlin-Bicetre (KB) and Institut Gustave Roussy (IGR) are stored on a server at Institut Gustave Roussy (IGR). The data are available from the first author upon request subject to ethical review.